These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 26849902)

  • 1. TGF-β: the connecting link between nephropathy and fibrosis.
    Sutariya B; Jhonsa D; Saraf MN
    Immunopharmacol Immunotoxicol; 2016; 38(1):39-49. PubMed ID: 26849902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of thioredoxin-interacting protein ameliorates high glucose-induced epithelial to mesenchymal transition in renal tubular epithelial cells.
    Wei J; Shi Y; Hou Y; Ren Y; Du C; Zhang L; Li Y; Duan H
    Cell Signal; 2013 Dec; 25(12):2788-96. PubMed ID: 24041652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactive oxygen species amplify glucose signalling in renal cells cultured under high glucose and in diabetic kidney.
    Ha H; Lee HB
    Nephrology (Carlton); 2005 Oct; 10 Suppl():S7-10. PubMed ID: 16174288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy.
    Wang SN; LaPage J; Hirschberg R
    Kidney Int; 2000 Mar; 57(3):1002-14. PubMed ID: 10720953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy.
    Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK
    Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy.
    Elmarakby AA; Sullivan JC
    Cardiovasc Ther; 2012 Feb; 30(1):49-59. PubMed ID: 20718759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-β/Smad signalling in diabetic nephropathy.
    Lan HY
    Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):731-8. PubMed ID: 22211842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effects of particulate matter and substrate stiffness on epithelial-to-mesenchymal transition.
    Barker TH; Dysart MM; Brown AC; Douglas AM; Fiore VF; Russell AG;
    Res Rep Health Eff Inst; 2014 Nov; (182):3-41. PubMed ID: 25669020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury.
    Noh H; Oh EY; Seo JY; Yu MR; Kim YO; Ha H; Lee HB
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F729-39. PubMed ID: 19553350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different roles for TGF-beta and VEGF in the pathogenesis of the cardinal features of diabetic nephropathy.
    Ziyadeh FN
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S38-41. PubMed ID: 18842317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects.
    López-Hernández FJ; López-Novoa JM
    Cell Tissue Res; 2012 Jan; 347(1):141-54. PubMed ID: 22105921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction.
    Sato M; Muragaki Y; Saika S; Roberts AB; Ooshima A
    J Clin Invest; 2003 Nov; 112(10):1486-94. PubMed ID: 14617750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quercetin inhibits the mTORC1/p70S6K signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in diabetic nephropathy.
    Lu Q; Ji XJ; Zhou YX; Yao XQ; Liu YQ; Zhang F; Yin XX
    Pharmacol Res; 2015 Sep; 99():237-47. PubMed ID: 26151815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collagen VIII influences epithelial phenotypic changes in experimental diabetic nephropathy.
    Loeffler I; Liebisch M; Wolf G
    Am J Physiol Renal Physiol; 2012 Sep; 303(5):F733-45. PubMed ID: 22759394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats.
    Okada M; Takemura T; Yanagida H; Yoshioka K
    Kidney Int; 2002 Jan; 61(1):113-24. PubMed ID: 11786091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth factors, cytokines, and renal fibrosis during the course of diabetic nephropathy.
    Rossert J; Terraz-Durasnel C; Brideau G
    Diabetes Metab; 2000 Jul; 26 Suppl 4():16-24. PubMed ID: 10922969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Glimpse of the Mechanisms Related to Renal Fibrosis in Diabetic Nephropathy.
    Zeng LF; Xiao Y; Sun L
    Adv Exp Med Biol; 2019; 1165():49-79. PubMed ID: 31399961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smad3 linker phosphorylation attenuates Smad3 transcriptional activity and TGF-β1/Smad3-induced epithelial-mesenchymal transition in renal epithelial cells.
    Bae E; Kim SJ; Hong S; Liu F; Ooshima A
    Biochem Biophys Res Commun; 2012 Oct; 427(3):593-9. PubMed ID: 23022526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparanase is a key player in renal fibrosis by regulating TGF-β expression and activity.
    Masola V; Zaza G; Secchi MF; Gambaro G; Lupo A; Onisto M
    Biochim Biophys Acta; 2014 Sep; 1843(9):2122-8. PubMed ID: 24937189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular matrix as a contextual determinant of transforming growth factor-β signaling in epithelial-mesenchymal transition and in cancer.
    Cichon MA; Radisky DC
    Cell Adh Migr; 2014; 8(6):588-94. PubMed ID: 25482625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.